ALOX5 and CDH1-related diffuse gastric and lobular breast cancer syndrome: Therefore, the PI3K/5‐LOX/LTB4 axis not only clarified a distinct interactive pattern in LBC‐TIME crosstalk, but also sheds light on the promising future of synergistic treatment regimens of targeted therapy and immunotherapy for refractory advanced LBC patients.